Literature DB >> 27908608

A hospital-based survey of patients with severe valvular heart disease in China.

Po Hu1, Xian-Bao Liu1, Jie Liang1, Qi-Feng Zhu1, Chao-Xia Pu2, Meng-Yao Tang3, Jian-An Wang4.   

Abstract

OBJECTIVES: Due to increasing aging, the epidemiology of VHD may have changed in China. This study aimed to provide contemporary information on the prevalence, distribution patterns, and etiology of severe VHD in China.
METHODS: This was a retrospective survey at Second Affiliated Hospital of Zhejiang University, which included all consecutive patients between 2010 and 2015.
RESULTS: In all, 139,496 patients were enrolled. Among severe valve diseases, MR was the most frequent (n=946, 0.68%) followed by MS (n=524, 0.38%), AS (n=392, 0.28%), and AR (n=371, 0.27%). Severe MR and AS prevalence rates increased strikingly with age. Rheumatic heart disease had an prevalence of 1.56% (n=2179), and remained one of the most common causes of severe VHD in patients younger than 65years old (99.5% of MS with rheumatic; 27.6% of MR with rheumatic; 25.7% of AS with rheumatic; 31.6% of AR with rheumatic). Aortic valve calcification was the predominant AS etiology, and its prevalence greatly increased with age. In severe AR, rheumatic fever was the most common etiology in patients below 65; in those above 65, etiology was mostly degenerative. In severe primary MR, mitral valve prolapse was the most common cause. Prevalence of secondary MR increased with age, from 16.4% in 18-44years old to 51.7% in individuals ≥75.
CONCLUSIONS: Severe valvular diseases are very common; rheumatic fever and degenerative valvular changes remain predominant causes in patients below 65 and older ones, respectively. Young adults present mainly with primary MR, while secondary MR is more common in elderly ones.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  China; Epidemiology; Severe; Valvular heart disease

Mesh:

Year:  2016        PMID: 27908608     DOI: 10.1016/j.ijcard.2016.11.301

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

1.  Disturbed energy and amino acid metabolism with their diagnostic potential in mitral valve disease revealed by untargeted plasma metabolic profiling.

Authors:  Limiao Jiang; Jing Wang; Rui Li; Ze-Min Fang; Xue-Hai Zhu; Xin Yi; Hongwen Lan; Xiang Wei; Ding-Sheng Jiang
Journal:  Metabolomics       Date:  2019-04-01       Impact factor: 4.290

2.  Midrange ejection fraction as a risk factor for deterioration of cardiofunction after permanent pacemaker implantation.

Authors:  Hua He; XiaoDong Li; BingBing Ke; Zhuo Chen; FuSheng Han; YuJie Zeng
Journal:  J Interv Card Electrophysiol       Date:  2019-02-09       Impact factor: 1.900

3.  Economic Evaluation of Transcatheter Aortic Valve Replacement Compared to Surgical Aortic Valve Replacement in Chinese Intermediate-Risk Patients.

Authors:  Weicong Zhang; Yake Lou; Yujiang Liu; Hongwei Wang; Chun Zhang; Linxue Qian
Journal:  Front Cardiovasc Med       Date:  2022-05-26

4.  Prevalence and modifiable risk factors of degenerative valvular heart disease among elderly population in southern China.

Authors:  Shang-Fei He; Jun-Rong Jiang; Fang-Zhou Liu; Hong-Tao Liao; Yu-Mei Xue; Mu-Rui Zheng; Huo-Xing Li; Hai Deng; Shu-Lin Wu
Journal:  J Geriatr Cardiol       Date:  2021-07-28       Impact factor: 3.327

Review 5.  LARIAT Trial Updates.

Authors:  Dan Musat; Suneet Mittal
Journal:  J Atr Fibrillation       Date:  2018-06-30

Review 6.  Rheumatic heart disease across the Western Pacific: not just a Pacific Island problem.

Authors:  Marian Abouzeid; Judith Katzenellenbogen; Rosemary Wyber; David Watkins; Timothy David Johnson; Jonathan Carapetis
Journal:  Heart Asia       Date:  2017-10-05

7.  Effect of Treprostinil on the Early Postoperative Prognosis of Patients with Severe Left Heart Valvular Disease Combined with Severe Pulmonary Hypertension.

Authors:  Shu-Ting Huang; Ning Xu; Kai-Peng Sun; Qiang Chen; Hua Cao
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-06-03       Impact factor: 1.520

8.  The Evolving Epidemiology of Elderly with Degenerative Valvular Heart Disease: The Guangzhou (China) Heart Study.

Authors:  Shangfei He; Hai Deng; Junrong Jiang; Fangzhou Liu; Hongtao Liao; Yumei Xue; Murui Zheng; Huoxing Li; Shulin Wu
Journal:  Biomed Res Int       Date:  2021-04-23       Impact factor: 3.411

9.  Current status and etiology of valvular heart disease in China: a population-based survey.

Authors:  Ying Yang; Zengwu Wang; Zuo Chen; Xin Wang; Linfeng Zhang; Suning Li; Congyi Zheng; Yuting Kang; Linlin Jiang; Zhenhui Zhu; Runlin Gao
Journal:  BMC Cardiovasc Disord       Date:  2021-07-13       Impact factor: 2.298

10.  Midterm postoperative prognosis of patients with severe left heart valvular disease combined with moderate or severe pulmonary hypertension treated with treprostinil.

Authors:  Ning Xu; Shu-Ting Huang; Kai-Peng Sun; Zeng-Chun Wang; Hua Cao; Qiang Chen
Journal:  BMC Cardiovasc Disord       Date:  2020-11-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.